IRVINE, Calif. (December 12, 2018)
– Hoag Orthopedic Institute (HOI), one of the largest providers of orthopedic
care in the nation, is the only Southern California hospital participating
in the newly launched, multi-site Zimmer Biomet mymobility™ Clinical
Study, which seeks to assess the impact on patient outcomes and overall
costs for as many as 10,000 joint replacement patients across the nation.
HOI is one of 18 sites throughout the U.S. participating in the trial
which officially launched on October 15, 2018.
Millions of Americans receive a hip or knee replacement each year, making
the procedures two of the most commonly performed in the country. Zimmer
Biomet’s mymobility app, used in conjunction with an Apple Watch®
wrist wearable device and iPhone® mobile digital device, will act
as a virtual and continuous care team on each patient’s wrist.
The app has several features that use both Apple Watch and the iPhone,
including the ability for surgeons to send education and therapy reminders
directly to the patient’s Apple Watch. The app also allows surgeons
to monitor patient activity levels throughout the days and weeks while
they are preparing for and recovering from surgery.
“Our research team is looking forward to analyzing the efficacy of
this novel approach to tracking patients before and after joint replacement
surgery,” said Dr. Steven Barnett, an orthopedic surgeon and principal
investigator for the study at Hoag Orthopedic Institute. “The ability
to accurately track the activity levels of our patients will give us quantitative,
unbiased measurements to further enhance and improve upon our patients’
experiences throughout the continuum of care.”
In what will be one of the largest evidence-gathering clinical studies
in orthopedic history, HOI will be able to combine patient-reported feedback
with the continuous health and activity data gathered by the Apple Watch
to guide patients through pre- and post-op care.
“We’re excited at the prospect of using the data and insights
gleaned from this innovative study to continue to drive value and improve
care for our patients,” said Jennifer Mitzner, CEO of Hoag Orthopedic
Institute. “This is yet another example of how Hoag Orthopedic Institute
is forging the future of care delivery with its continued commitment to
advancements in digital solutions with the aim of improving the entire
continuum of care for those we serve.”
To learn more about the Zimmer Biomet mymobility Clinical Study, visit